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Gene expressiongh the action of two oncoproteins, large T antigen and small t antigen. Small t
antigen targets phosphatase PP2A, while large T antigen stimulates cell proliferation and survival by action
on multiple proteins, including the tumor suppressors Rb and p53. Large T antigen also binds components of
the transcription initiation complex and several transcription factors. We examined global gene expression in
SV40-transformed mouse embryo ﬁbroblasts, and in enterocytes obtained from transgenic mice. SV40
transformation alters the expression of approximately 800 cellular genes in both systems. Much of this
regulation is observed in both MEFs and enterocytes and is consistent with T antigen action on the Rb-E2F
pathway. However, the regulation of many genes is cell-type speciﬁc, suggesting that unique signaling
pathways are activated in different cell types upon transformation, and that the consequences of SV40
transformation depends on the type of cell targeted.
© 2009 Elsevier Inc. All rights reserved.IntroductionSV40 induces tumors when injected into newborn hamsters and is
also capable of inducing neoplastic transformation in cultured cells
and in transgenicmice (Ahuja et al., 2005). The transforming functions
of SV40 are carried by two proteins, the 708 amino acid large T antigen
(T antigen) and the 174 amino acid small t antigen (t antigen). Small t
antigen contributes to transformation by altering cellular signal
transduction pathways by binding to the PP2A holoenzyme and
displacing its regulatory subunits (Pallas et al., 1990). In many cases,
large T antigen is sufﬁcient to induce cellular transformation and
tumors in animals. T antigen has multiple transforming functions,
each of which is linked to its interaction with speciﬁc cellular targets.
Two key targets of T antigen are the tumor suppressors pRb and p53.
The Rb family of proteins (pRb, p107, p130) blocks progression of
the cell cycle at the G1/S boundary by binding to and inhibiting the
E2F family of transcription factors. The E2Fs control the expression of
a group of genes involved in cell cycle progression and thus are
required for DNA replication and progression through S phase. Under
normal circumstances, Rb proteins are normally controlled by
upstream signaling pathways that regulate their phosphorylation
state and thus their ability to interact with E2F proteins. However,
interaction with T antigen blocks the ability of Rb proteins to inhibit
E2Fs. Consequently, E2F-dependent gene transcription is effected
leading to S phase entry. One consequence of Rb protein inhibition is
the activation of the p53 pathway (Pipas and Levine, 2001) which, inl rights reserved.turn, results in the upregulation of a group of genes responsible for
blocking progression through the cell cycle and for inducing
apoptosis. T antigen also binds to p53 and blocks its ability to
stimulate gene expression (Pipas and Levine, 2001). Thus, the net
effect of T antigen action is to stimulate the expression of genes
required for S phase, while blocking the transcription of genes
involved in cell cycle arrest and cell death.
In addition to regulating gene expression through its actions on
tumor suppressors, T antigen also interacts directly with the cellular
transcription apparatus. T antigen binds TBP and a number of TBP-
associated proteins and appears to function as a TAF itself (Damania
and Alwine, 1996; Damania et al., 1998; Gruda et al., 1993; Johnston et
al., 1996). Consequently T antigen is a promiscuous activator of many
promoters (Gilinger and Alwine, 1993; Rice and Cole, 1993). In
addition, T antigen has been reported to interact with a number of
speciﬁc transcription factors such as TEF-1, AP-2 and SP1 (Johnston et
al., 1996; Mitchell et al., 1987). T antigen also enhances transcription
dependent on RNA polymerases I and III and SV40 infected cells have
higher levels of tRNA and rRNA synthesis than uninfected cells
(Baserga et al., 1978; Felton-Edkins and White, 2002; Larminie et al.,
1999; Sekiya and Oda, 1972; Zhai and Comai, 1999; Zhai et al., 1997).
These observations are consistent with early reports indicating that
global cellular transcription is increased upon SV40 infection (May et
al., 1976; Oda and Dulbecco, 1968).
Three other cellular proteins are known to bind to T antigen but
their role in SV40 transformation is not ﬁrmly established. Two of
these, Cul7 (Ali et al., 2004) and the spindle checkpoint kinase Bub1,
(Cotsiki et al., 2004) are known to bind to the amino terminus of T
antigen. The transcriptional adapter proteins p300/CBP bind to T
Fig. 1. Design of the mouse microarray experiments. Biological replicates of the mouse
intestine and MEF arrays were implemented as a block design and reference design,
respectively. Total RNA was isolated from control (C) and SV40-transformed (T) mouse
small intestine and MEFs. Total RNA was converted to cDNA and labeled with both Cy3
and Cy5 in independent reactions. Control and SV40-transformed cDNAwas mixed and
hybridized to the Agilent Mouse cDNA microarray in dye-swap fashion. The cDNA
microarray contains two duplicate arrays on one glass slide.
Table 1
Total number of SV40-regulated genes in MEF and intestine as a function of fold change
and p-value
Criteria M E V W
2-fold up 390 465 238 182
2-fold down 448 387 159 71
pb0.05 1400 1513 1719 1794
pb0.01 439 384 697 740
2-fold up And pb0.05 259 281 205 152
2-fold up And pb0.01 146 88 162 99
2-fold down And pb0.05 138 243 109 52
2-fold down And pb0.01 33 83 60 36
The microarray data was ﬁltered for each class of microarrays (M, MEF; E, Enterocyte; V,
Villi; W,Whole) using fold change and/or p-value. For example, “2-fold up”means that a
genewas upregulated in SV40 transformed cells at least 2-fold and “pb0.05”means that
a gene was differentially regulated from control cells at a p-value cutoff of 0.05. p-value
is a statistical measure that does not indicate whether a gene was up or downregulated.
184 P.G. Cantalupo et al. / Virology 386 (2009) 183–191antigen through its interaction with p53 (Eckner et al., 1996; Lill et al.,
1997; Poulin et al., 2004).
The study of SV40-induced transformation has utilized several
different biological systems including established cell lines, primary
cultured ﬁbroblasts, and transgenic mice. This body of work has ﬁrmly
established the importance of T antigen action on Rb-proteins and on
p53 in mediating transformation. However, several studies indicate
that the inhibition of pRb-proteins and p53 is not sufﬁcient and
suggest that, at least in some cases, action on additional cellular
targets is essential for T antigen-mediated transformation (Beachy et
al., 2002; Dickmanns et al., 1994; Dobbelstein et al., 1992; Manfredi
and Prives, 1990; Sachsenmeier and Pipas, 2001). Furthermore, other
studies demonstrate that even T antigen's action on Rb-proteins and
p53 is not always essential for transformation (Markovics et al., 2005;
Srinivasan et al., 1989). However, the interpretation of these studies is
complicated by the fact that some experiments were performed in
established mouse or rat cell lines, others used primary rat or mouse
cultures, and yet others used transgenic mice.
In this manuscript we compare the effects of SV40 transformation
on cellular gene expression in two systems: cultured primary mouse
embryo ﬁbroblasts and enterocytes derived from transgenic mice.
Speciﬁcally, we have used genemicroarray experiments in seeking the
answer to three questions: (1) does SV40-transformation deregulate
the expression of E2F-dependent genes; (2) does SV40-transformation
have common effects on the global patterns of cellular gene expression
in different cellular systems; and, (3) can gene expression proﬁling
identify additional pathways that might contribute to transformation?
Results
We compared the effects of SV40 early region on global patterns of
cellular gene expression in two different systems: cultured primary
mouse embryo ﬁbroblasts (MEFs), and intestinal epithelial cells
derived from transgenic mice. The experimental design is shown in
Fig. 1. SV40 induces morphological transformation in both of these
systems (Hauft et al., 1992; Todaro and Green, 1963). We also
examined the effects of SV40 transformation on cellular gene
expression in REF52 cells, an established rat cell line that has been
used extensively to study the mechanism of SV40 transformation
(Conzen and Cole, 1995; Srinivasan et al., 1989) (Fig. S1). By including
an analysis of REF52 cells, we can compare the patterns of geneexpression between a primary cell line, an established cell line and
intact tissue.
Parental or transformed MEF and REF52 sublines were maintained
in media supplemented with 10% fetal bovine serum and RNA was
isolated at two-days post-conﬂuence. Microarray experiments were
performed on three independently derived clones of SV40-trans-
formedMEFs or SV40-transformed REF52 cells. In each case, the SV40-
transformed cell line was directly compared to either parental REF52
cells or to the MEF primary culture from which the cell lines were
derived. In the case of the intestinal epithelium, enterocytes from
frozen intestinal sections were obtained by laser capture microdissec-
tion (LCM) and used to prepare RNA. The level of expression of SV40
large T antigen in MEFs, REF52, and enterocytes was similar (Fig. S2),
although small t antigen was not detected in enterocytes. In addition,
we examined the gene expression patterns in RNA samples from
whole intestines as well as from fractions enriched for villus
enterocytes from parental and transgenic mice (see below).
Microarray experiments were performed using either Agilent
mouse cDNA arrays or Affymetrix rat arrays. Mouse RNA from
intestine or MEFs was applied to the Agilent Mouse cDNA microarray
in dye-swap fashion (Churchill, 2002). We compared the three
independently derived transformed MEF sublines to a pool of control
MEFs. For intestine, we compared three independent samples of
SV40-transformed, LCM-captured enterocytes to three samples
obtained from their non-transgenic littermates. RNA from REF52 cell
lines was applied to the RGU34A chip (Affymetrix). We performed two
biological replicates of the untransformed REF52 cell line and three
biological replicates of SV40-transformed REF52 cells. A gene was
scored as being signiﬁcantly regulated if transformation resulted in a
change of 2-fold or more in the corresponding mRNA level. In
addition, genes with a p-value b=0.05 were scored as being
statistically regulated. Since our sample size is small (3–4 bioreplicates
for each class), applying a p-value cutoff may eliminate true-positives;
therefore, we used the biological relevance cutoff (2-fold) in our initial
characterization.
SV40 transformation alters cellular gene expression
Transformation by the SV40 early region altered the expression of
about 800 cellular genes in each system (Table 1). About 400 genes
were expressed at higher levels in SV40-transformed MEFs or
enterocytes compared to their nontransformed counterparts.
Approximately 400 genes were downregulated by transformation in
both MEFs and enterocytes. Thus, SV40 transformation results in the
altered expression of approximately 9% of the cellular genes
represented on the array. A complete list of the genes regulated in
each of these systems is shown in Table S1 and Table S2. In REF52 cells,
SV40 transformation alters the expression level of about 450 genes
(Table S3).
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signiﬁcant role in affecting the gene expression patterns of SV40
transformation. We conducted an immunoblot on various DNA
replication and cell cycle proteins with control and SV40-transformed
MEF lysates that were obtained from subconﬂuent (∼30% conﬂuent)
or two-day post-conﬂuent cells that were cultured in low (1%) or
normal (10%) levels of serum (Fig. S3). In all cases, SV40 transforma-
tion governed the steady-state level of the proteins tested irrespective
of the growth state of the cells or serum levels.
SV40 transformation regulates proliferation related genes in both mouse
embryo ﬁbroblasts and enterocytes
Next we compared the speciﬁc sets of genes in MEFs and
enterocytes that were regulated by SV40-transformation (Fig. 2) and
found that 179 genes (Table S4) were commonly upregulated in both
systems. Application of the GO-ontology software (DAVID, http://
david.abcc.ncifcrf.gov/home.jsp) to this set of genes indicated they
primarily belonged to four biological classes: DNA replication, DNA
repair, chromatin modiﬁers, and cell cycle regulators.
Many of these genes are known to be regulated by the E2F family of
transcription factors. Since SV40 large T antigen binds the Rb family of
tumor suppressor proteins, thus activating E2F-dependent transcrip-
tion, increased expression of genes regulated by E2Fs is a predicted
consequence of SV40-transformation. To test this we compiled a list of
42 well characterized E2F responsive genes (Table S5) and examined
their expression ratios in MEFs, enterocytes and REF52 cells. Nearly all
of these genes were expressed at higher levels in transformed cells in
all of these systems. We conclude that E2F-dependent transcription is
activated by SV40 transformation in each of these cases. A number of
other genes associated with cell cycle progression, DNA replication
and DNA repair, but not known to be directly regulated by E2F, also
showed increased expression upon SV40 transformation. At this point
we do not know if this upregulation is a direct consequence of SV40
transformation, or if it is an indirect consequence of cell cycle entry
and progression.
Only 36 genes were commonly downregulated by SV40 transfor-
mation in MEFs and enterocytes (Table S6). These do not appear to
belong to any speciﬁc biological class or reﬂect the activation or
repression of any speciﬁc pathway.
Distinct sets of cellular genes are altered by SV40 in mouse embryo
ﬁbroblasts and enterocytes
Our analysis revealed that many genes were uniquely regulated,
either in MEFs or enterocytes, by SV40 transformation (Fig. 2). For this
analysis, we did not consider genes that showed an upregulation
between 1.2- and 2-fold (84 genes for MEFs and 114 genes for
enterocytes). For instance, 128 genes were exclusively upregulated in
MEFs transformed by SV40, but were either not affected or down-Fig. 2. Analysis of SV40 regulated genes in MEFs and enterocytes. The intersection of the
were overlapped and visualized by Venn Diagrams. The number of genes in each set is indic
(1.2- to 2-fold) in the other class but did notmeet the 2-fold cutoff. Uniquely regulated genes
or are oppositely regulated. For instance, the 128 uniquely upregulated genes in transformeregulated in transformed enterocytes (b1.2-fold upregulation). Simi-
larly, 138 genes were uniquely upregulated in enterocytes, but were
either not changed or were downregulated in MEFs (b1.2-fold
upregulation). Similarly, some genes were uniquely downregulated
(273 in MEFs, 153 in enterocytes) upon transformation in each system.
According to the microarray data, genes regulated by SV40
transformation can be grouped into eight distinct classes (Table 2).
These include genes that are either upregulated (class 2) or down-
regulated (class 7) in bothMEFs and enterocytes. Six additional classes
represent genes that are commonly regulated in one of the systems,
but that are either not regulated or are oppositely regulated in the
other system. The differential regulation of several of these genes was
conﬁrmed by RT-PCR (Fig. 3) or immunoblot analysis (Fig. 4).
Many of the genes uniquely upregulated in SV40-transformed
MEFs (class 1) belong to a group whose expression is activated by the
interferon pathway (Table S7). In contrast, the levels of interferon-
regulated genes did not appear to be altered in SV40-transformed
enterocytes. Thus, in MEFs but not enterocytes, SV40-transformation
results in the activation of the interferon signaling pathway. At this
point it is unclear if SV40-transformation results in the increased
production of interferon, or if it directly upregulates the expression of
downstream target genes.
Two classes of genes, classes 3 and 4, contain genes that are
uniquely downregulated in SV40-transformed MEFs. Several of these
genes are important cell cycle regulators and growth factors such as
p21 (Cdkn1a), Igf2, cyclin D, p57 (Cdkn1c), Gadd45a and Tgfb3. In fact,
p21, Igf2 and cyclin D1 are upregulated in transformed enterocytes. On
the other hand, not all cell cycle regulators were uniquely down-
regulated in SV40-transformed MEFs. For example, cyclin E1 and
cyclin B2were found to bemembers of a class of genes, class 5, that are
uniquely upregulated in transformed enterocytes but not changed in
SV40-transformedMEFs. Themechanism and biological effect of these
differences in unclear.
We have previously reported that the transformation of enter-
ocytes by SV40 results in the coordinate downregulation of many
members of the cytochrome P450 detoxiﬁcation pathway (Saenz-
Robles et al., 2007b). This effect was not observed in SV40-
transformed MEFs perhaps due to low P450 gene expression (data
not shown). However, two detoxiﬁcation genes, Gstt1 (Fig. 3) and
vitamin D receptor (Table 2, class 6), were found to be upregulated in
transformed MEFs. At present, it is not clear how SV40 transformation
coordinately affects the mRNA levels of multiple members of this
pathway.
Gene regulation in the mouse intestine is not altered by the method of
cell isolation
To obtain the RNA used in the microarray experiments, MEFs
were treated with guanidine thiocyanate immediately following the
removal of culture medium and rinsing with PBS/EDTA. Thus, thegenes that were 2-fold up or 2-fold down in the MEF and enterocyte (E) microarrays
ated. The number above the inner circle represents genes that were regulated by array
are indicated by the inner circle. These genes show either no regulation in the other class
d MEFs are less than 1.2-fold upregulated in transformed enterocytes.
Table 2
Selected genes to represent classes of cell-type speciﬁc gene regulation
Classa Cloneb Name Genec Md pvale Ed pvale
1 751642 Ubiquitin speciﬁc peptidase 18 24110 3.55 0.00 0.24 0.87
871756 Tripartite motif protein 30 20128 3.49 0.01 0.11 0.50
616653 Interferon-induced protein with tetratricopeptide repeats 1 15957 3.13 0.00 −0.01 1.00
934836 Chromobox homolog 7 52609 1.86 0.04 −0.23 0.44
1380122 MutY homolog (E. coli) 70603 1.85 0.01 0.21 0.22
871077 Caspase 2 12366 1.69 0.01 0.05 0.83
442473 Plectin 1 18810 1.61 0.01 −0.05 0.78
920425 Histocompatibility 2, K1, K region 14972 1.54 0.02 −0.23 0.45
946107 RecQ protein-like 4 79456 1.52 0.00 0.16 0.25
618572 Interferon activated gene 203 15950 1.48 0.02 −0.07 0.84
2 335766 Timeless homolog (Drosophila) 21853 3.06 0.00 1.49 0.01
540239 DNA primase, p49 subunit 19075 3.02 0.00 3.92 0.02
761060 Chromatin assembly factor 1, subunit B (p60) 110749 2.93 0.00 2.90 0.01
540655 Minichromosome maintenance deﬁcient 5, cell division cycle 46 (S. cerevisiae) 17218 2.88 0.00 3.43 0.02
1053504 Polymerase (DNA directed), epsilon 18973 2.84 0.01 2.77 0.04
367559 Ubiquitin-like, containing PHD and RING ﬁnger domains, 1 18140 2.75 0.01 3.51 0.02
977156 Minichromosome maintenance deﬁcient 3 (S. cerevisiae) 17215 2.75 0.00 3.03 0.04
540946 Denticleless homolog (Drosophila) 76843 2.65 0.00 3.34 0.01
2101942 Minichromosome maintenance deﬁcient 4 homolog (S. cerevisiae) 17217 2.64 0.01 3.13 0.03
1037829 Proliferating cell nuclear antigen 18538 2.53 0.00 2.87 0.01
3 537489 Cyclin D1 12443 −2.75 0.05 1.13 0.20
336150 ChaC, cation transport regulator-like 1 (E. coli) 69065 −2.06 0.07 2.22 0.05
1001468 Solute carrier family 38, member 1 105727 −1.91 0.33 1.01 0.01
870931 Hexokinase 2 15277 −1.41 0.04 1.49 0.06
334351 Metallothionein 2 17750 −1.41 0.18 1.29 0.28
404131 Plasminogen activator, urokinase receptor 18793 −1.37 0.04 1.08 0.16
331379 Adenylate cyclase 4 104110 −1.33 0.04 1.85 0.08
517227 EP300 interacting inhibitor of differentiation 2 386655 −1.26 0.10 1.01 0.25
945526 Dimethylarginine dimethylaminohydrolase 1 69219 −1.06 0.12 2.18 0.08
851855 Phospholipase C, epsilon 1 74055 −1.04 0.16 1.02 0.07
4 536577 Dickkopf homolog 3 (Xenopus laevis) 50781 −5.03 0.03 −0.17 0.70
1277469 Insulin-like growth factor binding protein 2 16008 −3.71 0.03 −0.10 0.53
1277386 Cyclin D2 12444 −3.52 0.03 −0.11 0.74
1077628 Serine (or cysteine) peptidase inhibitor, clade A, member 3N 20716 −3.46 0.02 0.08 0.84
521599 UDP glucuronosyltransferase 2 family, polypeptide B36 231396 −3.11 0.02 −0.26 0.11
407674 Insulin-like growth factor binding protein 3 16009 −3.02 0.18 −0.15 0.41
517556 Glycine amidinotransferase (L-arginine:glycine amidinotransferase) 67092 −3.02 0.19 0.21 0.80
637211 Guanine deaminase 14544 −2.98 0.20 −0.24 0.42
1383367 CD24a antigen 12484 −2.86 0.17 0.03 0.87
463860 Platelet-derived growth factor, C polypeptide 54635 −2.85 0.01 0.00 0.99
5 1038400 Cyclin B2 12442 0.25 0.37 2.50 0.01
793009 Farnesyl diphosphate farnesyl transferase 1 14137 0.11 0.87 2.01 0.02
1279180 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 11987 −0.11 0.66 1.87 0.02
865281 RAN binding protein 5 70572 0.10 0.46 1.72 0.05
1005963 ZW10 interactor 52696 0.24 0.37 1.64 0.02
1023414 Periplakin 19041 0.16 0.50 1.56 0.02
523337 UCHL5 interacting protein 73738 0.01 0.93 1.54 0.00
331996 Inhibitor of DNA binding 1 15901 0.10 0.87 1.43 0.02
2102126 Methionine-tRNA synthetase 216443 0.05 0.81 1.41 0.01
821338 Core binding factor beta 12400 0.14 0.44 1.41 0.00
6 560431 Clusterin 12759 2.60 0.06 −1.60 0.28
1264311 Lymphocyte antigen 75 17076 1.58 0.04 −1.76 0.01
1331769 RAR-related orphan receptor gamma 19885 1.38 −2.33 0.02
809050 WD repeat domain 67 210544 1.24 0.00 −1.08 0.03
482898 Cysteine-rich protein 1 (intestinal) 12925 1.24 0.23 −1.38 0.01
348362 Cystin 1 12879 1.20 −1.05 0.05
571457 Period homolog 3 (Drosophila) 18628 1.11 0.11 −1.60 0.04
776764 Vitamin D receptor 22337 1.11 0.42 −1.92 0.01
458727 Leukotriene B4 receptor 1 16995 1.08 −1.17 0.01
596348 Aldehyde dehydrogenase family 1, subfamily A7 26358 1.00 0.21 −2.55 0.05
7 520782 NADPH oxidase 4 50490 −2.23 0.01 −1.21 0.04
791359 Yippee-like 2 (Drosophila) 77864 −1.40 0.03 −1.22 0.04
822692 TSC22 domain family, member 1 21807 −1.39 0.01 −1.11 0.00
355113 Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A 20358 −1.24 0.05 −1.54 0.01
992031 Glutaredoxin 93692 −1.19 0.08 −1.11 0.00
1125584 Protein phosphatase 1A, magnesium dependent, alpha isoform 19042 −1.16 0.04 −1.11 0.09
720411 Phytanoyl-CoA hydroxylase 16922 −1.11 0.07 −2.09 0.00
313537 5′ nucleotidase, ecto 23959 −1.09 0.06 −3.10 0.05
846412 RAB30, member RAS oncogene family 75985 −1.07 0.03 −2.19 0.06
1020807 Granule cell antiserum positive 14 72972 −1.02 0.00 −1.33 0.03
8 1096039 Bone morphogenetic protein 8a 12163 −0.25 0.55 −2.97 0.01
313629 Rhomboid domain containing 2 215160 −0.18 0.22 −2.22 0.02
1005129 Leukotriene B4 12-hydroxydehydrogenase 67103 −0.20 0.39 −2.16 0.01
386489 Cytidine deaminase 72269 −0.03 0.94 −1.91 0.00
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Table 2 (continued)
Classa Cloneb Name Genec Md pvale Ed pvale
1478742 Avian musculoaponeurotic ﬁbrosarcoma (v-maf) AS42 oncogene homolog 17132 −0.16 0.91 −1.91 0.01
1245874 Solute carrier family 2 (facilitated glucose transporter), member 5 56485 0.19 0.69 −1.89 0.02
440961 Glutamate-cysteine ligase , modiﬁer subunit 14630 0.02 0.93 −1.89 0.02
1004969 Solute carrier family 15 (H+/peptide transporter), member 2 57738 −0.04 0.88 −1.76 0.00
598741 N-acylsphingosine amidohydrolase 2 54447 0.10 0.20 −1.66 0.00
1106464 Sulfatase modifying factor 1 58911 0.01 0.92 −1.54 0.01
a Class number is the same as in Fig. 3.
b Unique identiﬁer, provided by Agilent, for each DNA sequence spotted on the array.
c NCBI Gene database unique identiﬁer.
d Average Log2 ratio for the MEF (M) and enterocyte (E) microarrays.
e P-value for the ratio.
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cells at the instant of extraction. In contrast, obtaining RNA from
enterocytes requires the removal, rinsing and ﬁxation of the small
intestine prior to the collection of enterocytes by LCM. Thus, since it
takes several minutes to prepare the intestine for LCM, it is possible
that the expression levels of some genes might be altered during this
period. Furthermore, the process of enterocyte enrichment by
biomechanical fractionation involves the use of several biochemical
and molecular procedures and results in an even longer delay
between intestine removal and RNA extraction (Markovics et al.,
2005). One way to reduce the possible effects of the extraction
method on gene expression would be to isolate RNA from whole
intestines that were extracted immediately after dissection. How-Fig. 3. Cell-type speciﬁc gene regulation is conﬁrmed by RT-PCR. Genes were selected to
represent different classes (“Class”) of cell-type speciﬁc genes that were observed by
microarray. cDNA was synthesized from 1 µg of total RNA from control (C) or SV40-
transformed (T) MEF or fractionated villi cells. Each gene was ampliﬁed with speciﬁc
primers by PCR and the products were resolved on a 2% agarose gel and stained with
GelStar. Ampliﬁcation with primers for the Rpl5 transcript was used as a normalizing
control. Up arrow, transcript is upregulated in SV40-transformed cells; down arrow,
downregulated; dash, transcript level not changed.ever, this method has the disadvantage of including muscle,
mesenchymal, and crypt progenitor cell populations in the prepara-
tion, in addition to enterocytes. Thus, gene responses unique to the
SV40-transformed cells would be diluted by these nontransformed
cell types.
To test for effects of the method of cell extraction on gene
expression, we performed microarray experiments on RNA isolated
from LCM-extracted enterocytes (E), fractionated villi (V), and whole
intestine (W). Table 1 shows that SV40 transformation regulates
more genes when cells are obtained by LCM than in those obtained
by fractionation or from whole intestine. We analyzed these data
sets in two ways. First, we focused on three speciﬁc regulated gene
sets (Fig. 5A): E2F responsive genes (Table S5), DNA replication
genes, and detoxiﬁcation genes (Saenz-Robles et al., 2007b). We
analyzed the expression pattern of the E2F responsive and DNA
replication genes that were upregulated at least 3-fold in all three
systems. For the detoxiﬁcation genes, we analyzed genes that were
downregulated at least 1.4-fold in all three systems. Second, we used
a nonbiased approach (Fig. 5B) by ﬁltering the microarray data by
ANOVA which resulted in 284 clones. These 284 clones show a
signiﬁcant difference in expression between the three systems. To
visualize the expression pattern of these differences we applied
hierarchical clustering to these clones and four patterns of gene
expression emerged (Fig. 5B). Both of these analyses show that
SV40-transformation regulates the same set of genes in samplesFig. 4. Microarray conﬁrmation by immunoblot. 50 µg of control (C) or SV40-
transformed (T) cell lysate from two-day post-conﬂuent MEFs and fractionated villi
were resolved by SDS-PAGE and transferred to PVDF. An appropriate primary antibody
was added (protein symbols shown on the left) and ECL Plus (Amersham) was used to
visualize protein expression. Gapdh was used as a loading control. The microarray
average log ratio from the MEF and enterocyte (E) arrays is shown on the right for each
gene.
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clearly show that LCM samples give the most robust ratios, followed
by fractionated villi and then by whole intestine. This is most likely
caused by the possible dilution of SV40-transformed cells with
nontransformed cell types: LCM would ensure that RNA is only
extracted from transformed enterocytes; villi fractionation would
remove most of the muscle, mesenchyme, and crypt cells but still
include goblet cells and enteroendocrine cells not expressing the
SV40 T antigens; and SV40-transformed cells would be most dilute
in whole intestine. LCM samples from liver were also shown to give
more robust microarray ratios than samples obtained from dissected
tissue (Yim et al., 2003).
Discussion
SV40 has been studied in many cell contexts including productive
infection, transformation in cell culture and transgenic mice, and is
known to alter the expression of many cellular genes. In fact, SV40-
induced transformation is closely linked to the control of cellular gene
expression. Large T antigen transforms, in part, by inhibiting Rb family
proteins and thus stimulating E2F-dependent transcription. In addi-
tion, T antigen antagonizes growth-arrest and pro-apoptotic signals by
binding the tumor suppressor p53 and thus blocking p53-dependent
transcription. Multiple lines of evidence suggest that there are
additional T antigen targets important for transformation, but how
they contribute to the process is unclear. Small t antigen contributes toFig. 5. Mouse intestine microarrays show similar patterns of gene expression. (A) The av
whole intestine (W), fractionated villi (V) and LCM extracted enterocyte (E) arrays is shown i
least 3-fold. In the bottom panel, detoxiﬁcation genes that are downregulated 1.4-fold or mo
enterocyte microarray data were ﬁltered by ANOVA (p=0.01) which resulted in 284 clones. T
Clones are colored red and green for clones that are up and downregulated in SV40-transfo
were revealed from the cluster diagram and the log ratio values of these clones are plotted
biological replicate.transformation by displacing the B subunits of the cellular phospha-
tase PP2A. In doing so, small t antigen alters several signal
transduction pathways, some of which ultimately affect gene expres-
sion (Nunbhakdi-Craig et al., 2003; Rodriguez-Viciana et al., 2006;
Watanabe et al., 1996).
In this study we have used genemicroarrays to compare the effects
of SV40-induced transformation on cellular gene expression in two
systems, cultured primary mouse embryo ﬁbroblasts and intestinal
enterocytes directly isolated from mice. SV40 transformation altered
the mRNA levels of about 800 cellular genes in both of these systems.
This likely represents an underestimate of the total number of
transformation-regulated genes for two reasons. First, the Agilent
arrays used in these studies only include 8462 of an estimated 21,000
mouse genes. Second, although we applied a 2-fold expression ratio
cutoff to the genes analyzed in our study, RT-PCR experiments
indicated that these expression ratios are compressed. Thus, many
genes whose expression ratios were less than but close to 2-fold were
actually regulated. Nevertheless, the patterns of gene expression
observed allow us to make several important conclusions.
Many genes associated with DNA replication, DNA repair, chroma-
tin assembly and modiﬁcation, and cell cycle progression were
upregulated by SV40-transformation in both MEFs and enterocytes.
This same set of genes was also upregulated in an SV40-transformed
established rat cell line, REF52. Approximately 80–90% of E2F-
regulated genes that were analyzed had elevated levels of mRNA in
transformed cells. The upregulation of genes associated with cell cycleerage log ratio of E2F responsive genes that were upregulated 3-fold or more in the
n the top panel. Similarly, the middle panel shows DNA replication genes upregulated at
re are shown. (B) The biological replicates of the whole intestine, fractionated villi and
hese clones were hierarchically clustered using Euclidean distance and average linkage.
rmed tissue, respectively. Grey clones represent missing data. Four expression patterns
on the right. The pink line represents the average log ratio for the set of clones in each
Fig. 6. Model for SV40 regulation of gene expression. The cell-type speciﬁc gene
regulation by SV40 is indicated by classes of genes that are uniquely or commonly
regulated in each cell type. For example, SV40 upregulates the interferon pathway in
MEFs and downregulates the detoxiﬁcation pathway in enterocytes.
189P.G. Cantalupo et al. / Virology 386 (2009) 183–191entry and progression was expected, as the virus-encoded large T
antigen is known to activate E2F-dependent gene expression and cell
cycle progression by binding and inactivating the Rb family of
proteins: pRb, p130, and p107. In fact, this group of upregulated
genes substantially overlapped with the upregulated genes found in
microarray studies using transgenic mouse models of breast,
prostrate, and lung cancer that express the early region of SV40
(Deeb et al., 2007; Klein et al., 2005).
We did not ﬁnd any evidence for activation of the p53 pathway.
This is expected since T antigen is known to block p53-dependent
transcriptional activation. Our studies also identiﬁed many genes
regulated by SV40 transformation that are not associated with cell
cycle control. These genes span multiple biological activities and at
this point their contribution to the transformed phenotype, if any, is
unclear. Future genetic studies should help elucidate their role.
More importantly, we found many genes that responded differen-
tially to the presence of T antigen, depending on the cell system under
consideration. For instance, we found increased mRNA levels of many
genes associated with the interferon pathway in transformedMEFs but,
in contrast, the expression of these geneswasnot altered in transformed
enterocytes. Strikingly, the levels of mRNAs encoding interferon alpha
and beta were not altered by the presence of the oncogene (data not
shown). This suggests that, in MEFs, one of the viral T antigens is either
directly binding and activating interferon-regulated promoters, or
activating the interferon signaling pathway.
Furthermore, we have previously reported that several genes
associated with the cytochrome P450 detoxiﬁcation pathway are
downregulated by the SV40 Tantigens in enterocytes (Saenz-Robles et
al., 2007b) but we found no evidence for regulation of this pathway in
SV40-transformed MEFs. Some cell cycle regulators such as cyclin D
and p21 and growth factors such as Igf2 and Tgfb3 were differentially
regulated in these systems. It is clear from our data that SV40 effects
on several pathways depend on the cell-type, but we do not yet
understand the mechanisms behind this cell-type speciﬁc effect or
know whether they contribute to transformation.
In conclusion, we have shown that SV40-transformation has both
common and unique effects on two different cell-types, cultured
primary MEFs and intestinal enterocytes directly obtained from mice
(Fig. 6). Many of the effects on gene expression that are common to
these systems can be explained by the action of large T antigen on the
Rb-E2F pathway. Small T antigen is known to regulate gene expression
(Moreno et al., 2004); therefore, a subset of the genes regulated by
SV40 transformation could be the result of small t expression. It is
unclear whether the genes that are uniquely regulated in MEFs or
enterocytes reﬂect differences between cells maintained in culture
and in vivo tissue or if the difference arose from the action of the viral
T antigens on targets that are speciﬁc to each cell type. The lack of
small t expression in enterocytes may contribute to these differences
as well. At this point, we cannot discern which changes in gene
expression are due to the direct action of T antigen on the
transcriptional apparatus, and which are the indirect consequence of
large and small T antigen action on signal transduction pathways.
Further studies in different cell types should render valuable
information to allow distinction of these mechanisms.
Materials and methods
Cell lines and transgenic mice
Wild-type MEFs and MEF sublines expressing the neomycin
resistance gene plus the early region of SV40 (Markovics et al., 2005),
which expresses the large and small T antigens, were maintained in
DMEM+10% heat inactivated FBS with 0.4 mg/ml G418. All cells were
grown at 37 °C in 5% CO2. REF52 cells expressing the neomycin
resistance gene with and without the early region of SV40
(Srinivasan et al., 1997) were maintained in MEM+10% FBS with0.4 mg/ml G418 (Invitrogen). The expression of the early region of
SV40 is driven by the Rous sarcoma virus promoter in both cell lines.
Transgenic mice expressing the SV40 early region under the control
of the rat intestinal fatty acid binding protein (IFABP) promoter were
previously described (Kim et al., 1993) and were maintained by
crosses to commercially available non-transgenic FVB mice (Taconic
Labs). Routine screenings for several murine pathogens and parasites
were all negative. Mouse genotyping was performed by PCR analysis
as described (Saenz-Robles et al., 2007a).
Isolation of intestinal epithelial cells
Mice between the ages of 1.5 to 3.5 months were sacriﬁced and
their entire small intestine was removed, opened longitudinally and
washed in saline solution. All non-transgenic intestine displayed a
normal morphology and each SV40-transformed intestine was judged
to be hyperplastic. No visible signs of polyps or tumors were present in
any intestinal sample. The intestine was subdivided into three
longitudinal portions equal in length, and the middle section was
harvested and used directly (“whole intestine”) or further processed
to enrich for villi structures (“fractionated villi”). The process for villi
enrichment has been described (Markovics et al., 2005; Saenz-Robles
et al., 2007a). Brieﬂy, middle sections of the intestine were incubated
for 30 min in PBS plus 1 mM DTT, and the villi subsequently released
by several steps of gentle shaking in the same solution supplemented
with 5 mM EDTA for the non-transgenic samples or 3 mM EDTA for
the T antigen-containing samples. Enterocytes from the villus were
obtained by laser capture microdissection (LCM) from middle section
intestinal rolls (Markovics et al., 2005). Brieﬂy, the rolls were quickly
frozen and stored at −80 °C. Frozen sections were cut and immediately
dehydrated in graded alcohol solutions. The dried sections were
examinedmicroscopically and the top two thirds of 50 villus segments
from each section were collected using a laser capture microscope
(PixCell II, Arcturus). The LCM captured cells were extracted in
PicoPure extraction buffer (Arcturus) according to the manufacturer's
directions and stored at −80 °C.
RNA extraction and puriﬁcation
Cell lines were grown to conﬂuence and fed with fresh medium.
After two days post-conﬂuence, cells were harvested with trypsin,
washed thrice with cold PBS-EDTA, and frozen at −80 °C. Total RNA
from MEF, whole and fractionated villi intestine samples was isolated
using the RNeasy kit (Qiagen) with DNase digestion. Enterocyte total
RNAwas isolated with the PicoPure kit (Arcturus) and ampliﬁed twice
with the RiboAmp kit (Arcturus).
190 P.G. Cantalupo et al. / Virology 386 (2009) 183–191Microarrays
For the MEF microarrays, we used a dye-swap reference design
(Churchill, 2002) to compare a pool of total RNA extracted from wild-
type MEFs to three independent SV40-transformed MEF cell lines. For
themouse small intestinemicroarrays, we used three different tissues,
whole, fractionated villi and LCM-captured enterocytes (described
above), in a dye-swap block design (Churchill, 2002) using three or
four non-transgenic and SV40-transformed mice for each intestine
preparation method. Where necessary, we pooled total RNA from up
to four mice to obtain enough total RNA for microarray analysis.
Each total RNA preparation was converted to Cy3- and Cy5-labeled
cDNA in independent reactions. Fifteen micrograms of total RNA was
incubated at 70 °C for 10 min in a 15.4 μl reaction that contained 6 μg of
oligo-dT (Operon, SP-230), or 7.5 μg of random primers (Roche,
11034731001) for reactions containing ampliﬁed enterocyte Total RNA.
After chilling the reactions on ice, labeled cDNAwas prepared by adding
3 μl of 1mMCy3-dUTP (AmershamBiosciences, PA53022) or 1mMCy5-
dUTP (PA55022) and 11.6 μl of a reverse transcription cocktail and the
reaction [13.3 U/μl SuperScript II Reverse Transcriptase (Invitrogen,
18065-022), 1× ﬁrst strand buffer, 10 mMDTT, 0.5 mM each dATP, dCTP,
dGTP and 0.2 mM of dTTP] was incubated at 42 °C for 2 h. RNA was
degraded by adding 1.5 μl of 1 N NaOH and 1.0 μl of 60mMEDTA to each
reaction and incubated at 65 °C for 10min. 470 μl of TE pH 7.4was added
to the reactionandapplied to aMicrocon-30ﬁlter (Millipore, 42410). The
reactions were centrifuged for 7 min at 8500 g and washed once with
400 μl of TE pH 7.4 to remove unincorporated dyes. Filters were
centrifuged upside-down to harvest the labeled cDNA (∼50 μl). Next,
control and SV40-transformed cDNA labeled with different dyes was
mixed and puriﬁed using the QIAQuick Kit (Qiagen). After completely
drying the cDNA in a vacuum centrifuge, the labeled cDNA was
resuspended in 7.5 μl of dH2O.
The Cy3/Cy5 cDNA mixture was applied to an Agilent Mouse cDNA
microarray (Agilent Technologies, G4104A), containing 9596 clones
representing 8462 unique genes, as recommended by themanufacturer.
Since there are two identical arrays printed on each Agilent glass slide,
labeled cDNA mixtures from a dye-swap pair (Cy5-SV40-transformed/
Cy3-control cDNA and Cy3-SV40-transformed/Cy5-control cDNA) was
applied to the separate arrays. After incubating themicroarray in a 65 °C
water bath for 17 h, the microarray was washed and dried according to
the manufacturer. Using an Affymetrix GMS418 scanner, two images
from each array were extracted by exciting the Cy3 dye at 532 nm and
the Cy5 dye at 635 nm and saved as a 16-bit TIFF ﬁle. The Cy3 and Cy5
images were aligned and quantitated with Imagene 5.5 (Biodiscovery).
The entire array was scanned manually to identify and ﬂag any spots
that were masked by debris or scratches. Additionally, any spots
whose signal was not greater than the spot background plus two times
the standard deviation of the spot background were ﬂagged. Each
array also contained a set of spots that were ﬂagged by Agilent. All
unﬂagged signals were normalizedwith a lowess intensity-dependent
smoother using BRB-Array Tools (National Cancer Institute, http://
linus.nci.nih.gov/BRB-ArrayTools.html) except that the lowess span
parameter was changed from 0.4 to 0.2. A log2 ratio was calculated for
each biological replicate by averaging its two dye-swap log ratios. In
the end, there are a total of three biological replicate ratios for theMEF
and enterocyte microarrays and four for the whole and villi
microarrays. The biological replicate log ratios for each class of
microarrays (MEF, enterocyte, whole, villi) were averaged and a one
sample t-test was performed to determine if the average log ratio was
signiﬁcantly different from the null hypothesis: log SV40-trans-
formed/control=0.
TIGR MeV 4.1 was used for the following statistical analyses. A
three-group ANOVA was performed on the biological replicate log
ratios of the whole intestine, fractionated villi and enterocyte
microarrays at a p-value=0.01 which resulted in 284 clones.
Hierarchical clustering using Euclidean distance and average linkagewas applied to the ANOVA clones. The distance threshold was set to
4.8 to reduce the number of terminal nodes to six.
Immunoblots
Protein extracts were prepared by lysing two-day post-conﬂuent
MEFs or fractionated villi in Buffer B [50 mM HEPES pH 7.9, 400 mM
KCl, 0.5mM EDTA, 0.1% NP40,10% glycerol, 1mMDTT, 0.5mMNa3VO4,
0.5 mMNaF, 1 μg/ml pepstatin and a protease inhibitor tablet (Roche)]
for 25 min at 4 °C. Cellular debris was cleared by centrifugation at
15,000 rpm for 30 min at 4 °C. Protein extracts were aliquoted and
stored at −80 °C until use. Lysate was resolved by SDS-PAGE and
transferred to PVDF (Millipore). After blocking with 10% non-fat milk
in 1× PBS, blots were probed with various antibodies: anti-Pola2
(kindly provided by Dr. Thomas Kelly), anti-Mcm (kindly provided by
Dr. Anthony Schwacha), anti-Rbl1 (Santa Cruz, sc-318), anti-Pcna
(DAKO, MO879), anti-Ccnd1 (Santa-Cruz, sc-450), anti-Irf7 (Santa-Cruz,
sc-9083) and anti-Gapdh (United States Biological, G8140-11). After
incubating the blots with an appropriate HRP-conjugated secondary
antibody, the blots were visualized with ECL Plus (Amersham).
RT-PCR
cDNA was synthesized from 1 μg of total RNA using Superscript II
Reverse Transcriptase (Invitrogen). PCR was performed with 1 μl of
cDNAusingGoTaqpolymerase (Promega) for 25 to 35 cycles (depending
on transcript being ampliﬁed) with speciﬁc primers for the following
genes (listed 5′–3′): Oas1a, TGGCTGAAGAGGCTGATGTGTG and TGAG-
GAAGGCTGGCTGTGATTG; Oasl2, TTACAGAACAGCCAGAGCTATACGG
and CAAGGGAGATAGATTTACGTCCACG; Suv39h1, CAGTGCTG-
GACTTGCTGGAAAC and TCCCTGAGACAATCTGTATGGACC; Cdkn1a,
GAACTTTGACTTCGTCACGGAGAC and CTTCAGGGTTTTCTCTTGCAGAAG;
Igf2, AAAGAAGCAGAAGAGACGCCCC and GCCAAAGAGATGAGAAGCAC-
CAAC; Tgfb3, AAGGAGTGGACAATGAAGATGACC and CTGAGCA-
GAAGTTGGCATAGTAACC; Cdkn1c, AAGAGAACTGCGCAGGAGAA and
CCCAGAGTTCTTCCATCGTC; Gadd45a, ACGACATCAACATCCTGCGG and
CAAAGTCATCTCTGAGCCCTCG; Srgap2, CCCAGCATTGCTAAGAGGAG
and GAGGCCTGGCAAGACTACAG; Ccne1, GCAGAAGGTCTCAGGTTATC
and GTGGCCTCCTTAACTTCAAG; Ccl5, ATATGGCTCGGACACCACTC and
CCACTTCTTCTCTGGGTTGG; Gstt1, TGTGTGAGAGTGTGGCTATCTTGC and
TTATGATGAGGTCAGCAGGGGGAC; Wnt5b, TGGAGACAACGTGGAGTACG
and GGCGACATCAGCCATCTTAT; Snrpn, GGTGGTGGAATTCAAGGAAA
and TTCCACAATAGCCGTTGTCA; Rpl5, CCAAACGATTCCCTGGTTATGAC
and GACGATTCCACCTCTTCTTCTTCAC. Ampliﬁcation with primers for
the Rpl5 transcript was used as a normalizing control. PCR reaction
products were resolved through a 2% agarose gel in 1× TAE and stained
with GelStar (Cambrex Bio Science).
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